central bank digital currency indonesia Top stories

Institution: The European Central Bank is paying attention to the weakness of the euro. The European Central Bank said yesterday that inflation is slowing down and hinted that it will cut interest rates again. However, Joost Van Leenders, an analyst at Van Lanschot kemen, said in a report that the European Central Bank will pay close attention to the recent weakness of the euro. As the import price rises, a weak currency may push up inflation. The senior investment strategist said that since the current deposit interest rate in the euro zone is 3% and the neutral interest rate is around 2%, the European Central Bank will cut interest rates at least four times. However, European Central Bank President Lagarde stressed that the inflation risk is two-sided.Destiny Tech100(DXYZ), a closed-end fund associated with SpaceX, a space exploration company owned by Musk, once fell more than 10%, and the refresh date was as low as $65.28. On December 11th, the price of the fund rose to $77.35, which was 567.38% higher than the closing price on November 5th (the polling day of the US election).Analyst: Britain's economic contraction for the second consecutive month sounded the alarm. AJ Bell analyst Danni Hewson said in a report that one month's data can't tell the whole story, but when the British economy contracted for two consecutive months-just like September and October-it is worthy of attention. The last time the economy contracted for two consecutive months was during the first pandemic blockade in 2020. She said that the uncertainty before the government budget may lead individuals and businesses to avoid spending for fear of possible tax increases. Bars, restaurants and art industries were hit hard in October. Hewson said that such discretionary expenses can be easily cut. In addition, looking back over the past six months, except August, the economic activity in each month was flat or decreased.

Bank of America: Investors poured into China stocks in recent weeks, and Bank of America strategists said that investors put money into China stocks again in the past week. In the week ending Wednesday, China equity funds received about $5.6 billion, the largest inflow in nine weeks, strategists such as Michael Hartnett quoted EPFR Global data as saying. He also believes that the first quarter of next year will be the entry point for non-US stocks. As investors have deployed a large number of positions for the rise in the yield of US dollars and US bonds, there is a risk of overshooting early next year. He believes that bonds, gold and international stocks are attractive under the assumption that persistent inflation forces the Fed to become more hawkish.Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).Jintou Chengkai: The major asset restructuring plan was changed to asset sale, and Jintou Chengkai announced that in order to further optimize the company's asset structure, enhance profitability, reduce the debt level, improve efficiency, speed up the transaction process and reduce transaction costs, the company plans to transfer 46.33% equity of its shareholding subsidiary Huafugong Company. The original planned major asset restructuring includes the transfer of 90% equity of Huachi Company, 46.33% equity of Huafugong Company and 31.89% equity of Tianfang Property Company, which is expected to constitute a major asset restructuring. The adjusted plan is to transfer 46.33% equity of Huafugong Company to Tianjin Investment Capital, the controlling shareholder of the company, through a non-public agreement at a price of 233 million yuan. After the completion of this transaction, the company no longer holds the equity of Huafugong Company. This transaction constitutes a related party transaction, but it does not constitute a major asset reorganization, and it needs to be submitted to the company's shareholders' meeting for consideration.

International Finance Association: In November, the net inflow of foreign investment in emerging market bonds and stock portfolios was $19.2 billion; The net outflow of foreign investment in emerging market stock markets was $11.1 billion; Debt inflows reached $30.4 billion.Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.China is a through train: a moderately loose monetary policy will be implemented in 2025. Recently, both Politburo meeting of the Chinese Communist Party and the Central Economic Work Conference decided that China will implement a moderately loose monetary policy next year. People close to the central bank said that the adjustment of monetary policy expression means that monetary policy will continue to maintain greater support for the real economy next year. In the current situation that the economic recovery is still facing many internal and external uncertainties and prices continue to run at a low level, this is very necessary, and it also reflects the central decision-making deployment of "implementing more active and promising macro policies". Judging from a series of recent policy operations and official statements, China's macro-control ideas are also being dynamically optimized, gradually paying more attention to investment from the past, paying equal attention to investment and consumption, and paying more attention to consumption change. People close to the central bank said that in the future, moderately loose monetary policy will be consistent with the overall macro-control thinking change, and more support will be given to promoting consumption and benefiting people's livelihood. (The country is a through train)